(Q39464358)

12 September 2017

1 reference

title

The beta-agonist controversy (English)

1 reference

12 September 2017

Taylor DR

1

1 reference

12 September 2017

Sears MR

series ordinal

2

1 reference

12 September 2017

Cockcroft DW

series ordinal

3

1 reference

12 September 2017

publication date

1 July 1996

1 reference

Medical Clinics of North America

12 September 2017

published in

1 reference

12 September 2017

volume

80

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

719-748

1 reference

Increase in hospital admissions for childhood asthma: trends in referral, severity, and readmissions from 1970 to 1985 in a health region of the United Kingdom

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Changes in bronchial reactivity in asthmatic children after treatment with beclomethasone alone or in association with salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long-term regularly inhaled salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Another word of caution regarding a new long-acting bronchodilator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long- versus short-acting beta 2-agonists. Implications for drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Some observations on the -adrenoceptor agonist properties of the isomers of salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

7 January 2021

The beta-agonist dilemma

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular vs as-needed inhaled salbutamol in asthma control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Respiratory arrests in young asthmatics on salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Ambulatory long-term subcutaneous salbutamol infusion in chronic severe asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular inhaled salbutamol and airway responsiveness to allergen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular use of inhaled albuterol and the allergen-induced late asthmatic response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The cardio-toxicity of isoprenaline during hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Asthma deaths in New Zealand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The effect of inhaled salmeterol on methacholine responsiveness in subjects with asthma up to 12 hours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The circumstances preceding death from asthma in young people in 1968 to 1969.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Enhancement of airway reactivity to histamine by isoprenaline and related beta-adrenoceptor agonists in the guinea-pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Tolerance with beta 2-adrenoceptor agonists: time for reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Absolute configuration of the optical isomers of salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Relative potency of (-)- and (+-)-salbutamol on guinea pig tracheal tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Inhaled therapy reduces morning dips in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Can the morbidity of asthma be reduced by high dose inhaled therapy? A prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Chirality in antirheumatic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Iatrogenic Asthma Associated with Adrenergic Aerosols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long-term studies on long-acting sympathomimetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Comparison of the effects of prolonged treatment with low and high doses of inhaled terbutaline on beta-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Is current treatment increasing asthma mortality and morbidity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Respiratory arrest in near-fatal asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular Inhaled Beta-Adrenergic Agonists in the Treatment of Bronchial Asthma: Beneficial or Detrimental?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long term treatment of severe asthma with subcutaneous terbutaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

An explanation of the asthma paradox

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Will I get addicted to my asthma treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Beta agonists and asthma mortality: déjà vu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

High-dose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Long-term effect of ipratropium bromide and fenoterol on the bronchial hyperresponsiveness to histamine in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Asthma induced by adrenergic aerosols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Prevalence of asthma in Melbourne schoolchildren: changes over 26 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Increased airway reactivity in the guinea-pig follows exposure to intravenous isoprenaline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Increasing asthma mortality--fact or artifact?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Dose reduction of beta-agonists in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Accuracy of certification of deaths due to asthma. A national study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular inhaled beta-agonist treatment in bronchial asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular versus symptomatic aerosol bronchodilator treatment of asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

The use of beta-agonists and the risk of death and near death from asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Association between asthma mortality and isoproterenol aerosols: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Regular inhaled beta agonist in asthma: effects on exacerbations and lung function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Comparison of four weeks' treatment with fenoterol and terbutaline aerosols in adult asthmatics *1A double-blind crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Evaluation of Oral Fenoterol in Chronic Asthmatic Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

How detrimental is chronic use of bronchodilators in asthma and chronic obstructive pulmonary disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Asthma control during and after cessation of regular beta 2-agonist treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

Prevalence of asthma and hay fever in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970465-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70465-X

1 reference

12 September 2017

1 reference